Fiduciary Alliance’s Exact Sciences EXAS Stock Holding History

Fiduciary Alliance’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-63	Closed	-$5.92K	–	426
2023 Q2	$5.92K	Buy	+63	New	+$4.92K	﹤0.01%	662

Other funds holding EXAS

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fiduciary Alliance's EXAS Position: Q3 2023 in Review

Fiduciary Alliance sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 63 shares — an estimated $5.92K sold.

Fiduciary Alliance first reported a position in EXAS in Q2 2023 and held it in 1 quarter. The position peaked at $5.92K in Q2 2023. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

Fiduciary Alliance reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
Fiduciary Alliance sold 63 Exact Sciences shares in Q3 2023, an estimated $5.92K.
Fiduciary Alliance first reported a position in Exact Sciences in Q2 2023 and held it in 1 quarter.
Fiduciary Alliance's Exact Sciences position peaked at $5.92K in Q2 2023.
624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.